DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Here, we performed a clinical, molecular genetic and microscopic study of a large monocentric cohort of dystrophinopathy patients harboring variants in their DMD gene and identified 13 putative disease-causing DMD small variants which had not been previously described in the literature, thus expanding the current genetic landscape of dystrophin-associated muscle diseases.